ROVI is a Spanish pharmaceutical company founded in 1946, headquartered in Madrid. It focuses on researching, developing, manufacturing, and commercializing pharmaceutical products. The company operates through three strategic pillars: a specialty pharmaceutical business, contract manufacturing services (CDMO), and an innovative R&D division.
ROVI's technical capabilities span advanced drug delivery systems, prefilled syringe manufacturing, oral solid forms, and low-molecular-weight heparins. Key proprietary technologies include the ISM® (In Situ Microparticles) platform for prolonged-release injectables and Bemiparin (Hibor®), a globally distributed low-molecular-weight heparin.
The company maintains a significant operational footprint with four manufacturing plants, three R&D centers, and a commercial presence in over 60 countries worldwide.
